# Cytovance Biologics Inc. – FDA Inspection, Jul 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/23b9870b-a1d7-4890-bb6f-c476414d80b4
Source feed: FDA_Inspections

> FDA inspection 1026556 of Cytovance Biologics Inc., July 20, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026556
- Company Name: Cytovance Biologics Inc.
- Inspection Date: 2017-07-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1322570 - 2026-06-17](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/56631e33-d2ff-4f1a-bdb8-d7a325ef8bd9)
- [FDA Inspection 1089182 - 2019-05-09](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/d6179c1f-7a2a-4cce-9010-40bb23f19661)
- FDA Inspection 1078729 - 2018-04-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.keypedia.com/companies/cytovance-biologics-inc/a03c370a-5e60-4617-95b1-521a1d305ac2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c